118 related articles for article (PubMed ID: 9838346)
1. Correlation between plasma glucocorticoids and clinical outcomes in living-related renal transplant recipients.
Shibata N; Ohmae T; Hoshino N; Minouchi T; Yamaji A; Park KI; Tomoyoshi T; Abe H; Kodama M
Transplant Proc; 1998 Nov; 30(7):3053-6. PubMed ID: 9838346
[No Abstract] [Full Text] [Related]
2. Conversion of cyclosporine to azathroprine in renal transplant recipients.
Bassiri A; Amiranssari B; Gol S
Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877
[No Abstract] [Full Text] [Related]
3. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
[No Abstract] [Full Text] [Related]
4. Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients.
Varghese Z; Abudher MN; Fernando ON; Moorhead JF
Transplant Proc; 2001 May; 33(3):2251-3. PubMed ID: 11377518
[No Abstract] [Full Text] [Related]
5. Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
Rudich SM; Bhaduri S; Chang T; Cahn J; Katznelson S; Perez RV
Transplant Proc; 1998 Jun; 30(4):1339-42. PubMed ID: 9636545
[No Abstract] [Full Text] [Related]
6. Role of postdose cyclosporine monitoring in living renal transplant recipients.
Thomas R; Minz M; Singh B; Heer M; Kashyap R
Transplant Proc; 2004 Sep; 36(7):2104. PubMed ID: 15518761
[TBL] [Abstract][Full Text] [Related]
7. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
[No Abstract] [Full Text] [Related]
8. Comparative study of adrenocortical function in renal transplant recipients under different long-term immunosuppressive therapy.
Hirano T; Shimodaira H; Oka K; Sakurai E; Kozaki K; Tamaki T; Kozaki M
Transplant Proc; 1993 Feb; 25(1 Pt 2):1359-60. PubMed ID: 8382858
[No Abstract] [Full Text] [Related]
9. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
Wahlberg J; Hanås E; Bergström C; Fellström B; Skarp-Orberg I; Frödin L
Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
[No Abstract] [Full Text] [Related]
10. Successful conversion from cyclosporine to azathioprine in elective renal transplant recipients.
Chuang FR; Hsieh H; Hsu KT; Chien YS; Chung HM
Transplant Proc; 1998 Nov; 30(7):3094-6. PubMed ID: 9838365
[No Abstract] [Full Text] [Related]
11. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
Siu CW; Chan TM; Li FK; Choy BY; Lui SL; Lo CY; Tang S; Lo WK; Lai KN
Transplant Proc; 2000 Nov; 32(7):1932-4. PubMed ID: 11120007
[No Abstract] [Full Text] [Related]
12. Long-term outcome of living-unrelated donor kidney transplantation.
Prabhakar KS; Vathsala A; Woo KT
Transplant Proc; 2000 Nov; 32(7):1807-8. PubMed ID: 11119945
[No Abstract] [Full Text] [Related]
13. Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
Malyszko J; Pawlak D; Pawlak K; Malyszko JS; Buczko W; Azzudin A; Mysliwiec M
Transplant Proc; 1996 Jun; 28(3):1954-7. PubMed ID: 8658959
[No Abstract] [Full Text] [Related]
14. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
15. Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine.
Oka K; Shimodaira H; Hirano T; Sakurai E; Tamaki T; Kozaki M
Transplantation; 1993 Sep; 56(3):603-9. PubMed ID: 8212155
[TBL] [Abstract][Full Text] [Related]
16. Renal recipients of haploidentical living donors treated with Neoral or conventional cyclosporine: a comparative follow-up of 3 years.
Gracida C; Melchor JL
Transplant Proc; 1998 Aug; 30(5):1742-3. PubMed ID: 9723262
[No Abstract] [Full Text] [Related]
17. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
Inoue S; Beck Y; Nagao T; Uchida H
Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
[No Abstract] [Full Text] [Related]
18. Adrenal function as an index of the immunosuppressive activity of glucocorticoids (prednisolone) in renal allograft recipients.
Kozaki M; Hirano T; Oka K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2237-9. PubMed ID: 3079076
[No Abstract] [Full Text] [Related]
19. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
[No Abstract] [Full Text] [Related]
20. Long-term graft survival of living-related kidneys after donor-specific transfusion.
Otsuka M; Yuzawa K; Takada Y; Taniguchi H; Fukunaga K; Seino K; Todoroki T; Fukao K
Transplant Proc; 2000 Nov; 32(7):1741-2. PubMed ID: 11119914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
